Mutares Enters Critical Fortnight With Covenants, Dividend, and a Czech Acquisition in the Mix

Mutares shares jump on €110M Synthomer acquisition, but a 29 June covenant deadline and 3 July AGM dividend vote pose near-term risks. Analysts see €41 target.

The Munich-based private equity group Mutares has kicked off a defining two-week stretch with a sharp share-price advance, though knotty bond covenants and a shareholder vote on dividends stand squarely in the way. On Friday the stock surged 3.7% to €29.40, snapping a prolonged slump and reclaiming ground above its 200-day moving average — a technical milestone that long-only investors often watch closely. The catalyst was news that Mutares is buying Synthomer, a Czech specialist in acrylate solutions that generates roughly €110 million in annual revenue. The acquisition, slated to close at the end of the third quarter of 2026, bolsters the firm’s chemicals and materials segment and marks another carved-out deal completed in a difficult environment, according to chief investment officer Johannes Laumann.

The share price has now recovered more than 26% from its April low of €23.30, and the relative strength index sits at 63.5 — warm but still well short of overbought territory. Yet the chart alone cannot mask the immediate risk hanging over the equity: a covenant compliance deadline on 29 June. Mutares breached leverage ratios on two of its bonds late last year, and creditors granted a reprieve until that date. The company aims to have the metrics back in line by then, and management has publicly committed to slashing total outstanding bonds from €385 million to as little as €250 million by the end of 2026. A second miss, however, would hit the stock hard and could overshadow the upbeat deal-making momentum.

That covenant suspense will be swiftly followed by the annual general meeting in Munich on 3 July. The agenda includes a proposed base dividend of €2.00 per share, with the ex-dividend date set for 6 July and payment two days later. Many investors are also eyeing a potential performance dividend tied to successful portfolio exits, though the final decision rests with the AGM and depends heavily on realised disposal gains in 2025.

Beyond the nearby deadlines, the exit pipeline remains the most powerful medium-term lever. Mutares is exploring strategic options for Magirus, its firefighting vehicle unit, and an initial public offering has not been ruled out. The division’s order backlog already exceeds €880 million, providing a solid foundation for a lucrative sale. Meanwhile, the soon-to-be-completed divestment of NEM Energy to Hyundai Heavy Industries is expected to deliver fresh cash during the third quarter of 2026 — just as the Synthomer carve-out is being sealed on the other side of the balance sheet.

Analysts at Warburg Research have set a target price of €41.00, betting that a successful covenant resolution and a steady stream of exits will unlock value. For now, the equity has reclaimed its 200-day line at €28.96, and if it can hold above €30 in the coming week, the path toward last year’s record high could reopen. But the covenant tripwire on 29 June remains the single biggest variable: a clean pass would refocus attention on dividends and disposals, while any misstep would swiftly erode the technical gains that have taken months to rebuild.